|
|
|
|
| LEADER |
01117naa a2200277 i 4500 |
| 001 |
NSK01000983606 |
| 003 |
HR-ZaNSK |
| 005 |
20180125130313.0 |
| 007 |
ta |
| 008 |
180116s2015 ci | |1|| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)000983606
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 615
|2 2011
|
| 080 |
1 |
|
|a 616
|2 2011
|
| 100 |
1 |
|
|a Jesus, Cátia
|4 aut
|
| 245 |
1 |
2 |
|a A review of the evidence for the use of metformin in the treatment of metabolic syndrome caused by antipsychotics /
|c Cátia Jesus, Inês Jesus, Mark Agius.
|
| 500 |
|
|
|a 5th Biennial Cambridge & Bedford International Conference on Mental Health, Cambridge, 11th-14th September 2015
|
| 504 |
|
|
|a Bibliografija: 20 jed.
|
| 653 |
|
0 |
|a Psihijatrijski pacijenti
|a Antipsihotici
|a Atipični antipsihotici
|a Metabolički sindrom
|a Dislipidemija
|a Dijabetes
|a Debljina
|a Metformin
|
| 700 |
1 |
|
|a Jesus, Inês
|4 aut
|
| 700 |
1 |
|
|a Agius, Mark
|4 aut
|
| 773 |
0 |
|
|t Psychiatria Danubina. Supplement
|x 1332-1366
|g 27 (2015), 1 ; str. 489-491
|w nsk.(HR-ZaNSK)000009867
|
| 981 |
|
|
|b B07/15
|
| 998 |
|
|
|a mamo1801
|a migd1801
|